LivaNova Q3: Revenue Up 9.9% but $34M Heater-Cooler Charge Cuts Operating Income to $28.4M
LIVN sits 98% above its 52-week low of $48.82 on elevated volume (4.1× avg).
Summary
LivaNova's Q3 revenue rose 9.9% to $393.1M, but a $34.0M 3T Heater-Cooler litigation charge cut GAAP operating income to $28.4M from $54.0M a year ago. The SNIA settlement hearing slipped from December 2026 to February 2027.
Key Events · Earnings and Guidance · LIVN
-
Q3 Revenue Grows 9.9% to $393.1M
Revenue rose to $393.1M from $357.8M, with Cardiopulmonary up 10.9% to $225.3M and Neuromodulation up 11.1% to $166.1M. Nine-month revenue was $1,146.0M, up 11.6%.
-
$34.0M Heater-Cooler Charge Hits Operating Income
The 3T Heater-Cooler litigation provision rose by $34.0M in Q3 and $45.3M for the nine months, taking the total provision to $44.2M from $15.6M at December 31, 2025. GAAP operating income fell to $28.4M from $54.0M.
-
Cardiopulmonary Segment Income Down 69.3%
Cardiopulmonary segment income fell to $7.6M from $24.7M on the litigation charge, while Neuromodulation rose 10.6% to $62.1M. Total segment income was $69.7M versus $80.9M.
-
SNIA Settlement Hearing Pushed to February 2027
The Court of Appeal moved the settlement discussion from December 9, 2026 to February 10, 2027. The $383.6M SNIA liability is unchanged and management says it has sufficient resources to cover it.
Analysis · LIVN · Industrial Applications And Services
The headline numbers were already out this morning — $393.1M of revenue, up 9.9%, and adjusted EPS of $1.23 — but the 10-Q shows what the adjusted figure hides. A $34.0M charge for the 3T Heater-Cooler litigation in the quarter (and $45.3M for the nine months) pushed GAAP operating income down to $28.4M from $54.0M a year ago, and Cardiopulmonary segment income fell 69.3% to $7.6M. The provision now stands at $44.2M versus $15.6M at year-end, so the claims are getting more expensive, not less. On the other side, the $383.6M SNIA environmental liability is unchanged and management says it has sufficient resources to cover it, with $563.5M of cash plus a fully undrawn $225.0M revolver. The settlement hearing that had been set for December 9, 2026 has slipped to February 10, 2027, which pushes the resolution date out another two months.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LIVN was trading at $96.42 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.3B. The 52-week trading range was $48.82 to $99.38. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.